OS

Omprakash Shiva Nath Asawa

Active Director Director DIN 07305276
DIN 07305276 First appointment Dec 2015 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Omprakash Shiva Nath Asawa

Data last updated:

Omprakash Shiva Nath Asawa is a Director at Kavya Pharmaceuticals Private Limited (since 2015). The company operates in Healthcare.

DIN 07305276
Primary Designation Director
Industry Healthcare
First Appointment 02 Dec 2015
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Dec 20152015Active

Board colleagues of Omprakash Shiva Nath Asawa

NameDINCompanyDesignation
Shrikant Bhagwat Mishra07305284Kavya Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kavya Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Omprakash Shiva Nath Asawa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Omprakash Shiva Nath Asawa

Omprakash Shiva Nath Asawa currently holds 1 directorship: Kavya Pharmaceuticals Private Limited (Director, since 02 Dec 2015).

Omprakash Shiva Nath Asawa was first appointed on 02 Dec 2015 as Director at Kavya Pharmaceuticals Private Limited.

The current boards of Omprakash Shiva Nath Asawa's companies include Shrikant Bhagwat Mishra (Kavya Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available